Transparent Life: Intends to acquire controlling stake in Wuhan Kanglu Biological Technology Co., Ltd.

date
04/08/2025
Transparent Life announced that the company plans to acquire 72.8630% of the shares of Wuhan Kanglu Biological Technology Co., Ltd. After the completion of the acquisition of 72.8630% of Kanglu Biotechnology, Kanglu Biotechnology will become a subsidiary of the company and be included in the company's consolidated financial statements. In 2026 and 2027, if the conditions stipulated in the relevant agreements of this transaction are met, the company will further purchase 9.1370% of the shares of Kanglu Biotechnology held by Chen Gang and Xie Jun. After the completion of the aforementioned three-step acquisitions, the company will collectively hold 82.00% of the shares of Kanglu Biotechnology.